UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

British journal of cancer, 2011-04, Vol.104 (9), p.1418-1425

2011

Volltextzugriff (PDF)

Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study

Annals of oncology, 2015-07, Vol.26 (7), p.1363-1371

2015

Volltextzugriff (PDF)

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

Oncogene, 2012-10, Vol.31 (42), p.4559-4566

2012

Volltextzugriff (PDF)

A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment

Annals of oncology, 2016-08, Vol.27 (8), p.1511-1519

2016

Volltextzugriff (PDF)

PO-102: EGFR detection in saliva as an easy diagnostic and prognostic tool in oral squamous cell cancer

Radiotherapy and oncology, 2017-03, Vol.122, p.49-49

2017

Volltextzugriff (PDF)

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy

British journal of cancer, 2013-07, Vol.109 (2), p.462-471

2013

Volltextzugriff (PDF)

Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas

British journal of cancer, 2008-09, Vol.99 (5), p.768-773

2008

Volltextzugriff (PDF)

Claudin‐7 expression in human epithelial ovarian cancer

International journal of gynecological cancer, 2008-11, Vol.18 (6), p.1262-1271

2008

Volltextzugriff (PDF)

881 MicroRNA Expression Profiling of Stage I Ovarian Carcinoma Reveals Signatures Characterizing the Different Tumor Grades and Histotypes

European journal of cancer (1990), 2012-07, Vol.48, p.S213-S213

2012

Volltextzugriff (PDF)

Mammaglobin B expression in human endometrial cancer

International journal of gynecological cancer, 2008-09, Vol.18 (5), p.1090-1096

2008

Volltextzugriff (PDF)

8040 POSTER Diagnostic and Prognostic Significance of CA125 and HE4 in Ovarian Cancer Patients

European journal of cancer (1990), 2011, Vol.47, p.S539-S539

2011

Volltextzugriff (PDF)

1459 POSTER HE4 Levels in Endometrial Cancer Patients – Potential Role as a Tumour Biomarker

European journal of cancer (1990), 2011, Vol.47, p.S187-S187

2011

Volltextzugriff (PDF)

Identification of stably expressed reference small non‐coding RNAs for microRNA quantification in high‐grade serous ovarian carcinoma tissues

Journal of cellular and molecular medicine, 2016-12, Vol.20 (12), p.2341-2348

2016

Volltextzugriff (PDF)

Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes

Frontiers in immunology, 2021-06, Vol.12, p.690201-690201

2021

Volltextzugriff (PDF)

RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients

Scientific reports, 2017-09, Vol.7 (1), p.10528-10528, Article 10528

2017

Volltextzugriff (PDF)

Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients

Frontiers in oncology, 2020-09, Vol.10, p.584022-584022

2020

Volltextzugriff (PDF)

964P Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways

Annals of oncology, 2020-09, Vol.31, p.S680-S680

2020

Volltextzugriff (PDF)

Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients

Archives of virology, 2006-10, Vol.151 (10), p.1899-1916

2006

Volltextzugriff (PDF)

HE4 in gynecological cancers: report of a European investigators and experts meeting

Clinical chemistry and laboratory medicine, 2012-12, Vol.50 (12), p.2127-2136

Plebani, Mario

2012

Volltextzugriff (PDF)

Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues

PloS one, 2014-12, Vol.9 (12), p.e113781-e113781

2014

Volltextzugriff (PDF)

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis

BMC cancer, 2017-05, Vol.17 (1), p.366-366, Article 366

2017

Volltextzugriff (PDF)

Induction of tumour-specific CD8 cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer

British journal of cancer, 2002-01, Vol.86 (1), p.151-157

2002

Volltextzugriff (PDF)

Intracellular localization of full-length and truncated hepatitis C virus core protein expressed in mammalian cells

Journal of hepatology, 1994, Vol.20 (6), p.833-836

1994

Volltextzugriff (PDF)

Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer

Gynecologic and obstetric investigation, 2001-01, Vol.51 (4), p.254-261

2001

Volltextzugriff (PDF)

172 Trefoil factor 3: a potential diagnostic and prognostic marker whose expression contributes to malignant feature in endometrial carcinoma cells

European journal of cancer supplements, 2010, Vol.8 (5), p.45-45

2010

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(142)

Publikationsform

Artikel
(162)
Tagungsberichte
(2)

Sprache

Englisch
(164)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment

PO-102: EGFR detection in saliva as an easy diagnostic and prognostic tool in oral squamous cell cancer

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy

Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas

Claudin‐7 expression in human epithelial ovarian cancer

881 MicroRNA Expression Profiling of Stage I Ovarian Carcinoma Reveals Signatures Characterizing the Different Tumor Grades and Histotypes

Mammaglobin B expression in human endometrial cancer

8040 POSTER Diagnostic and Prognostic Significance of CA125 and HE4 in Ovarian Cancer Patients

1459 POSTER HE4 Levels in Endometrial Cancer Patients – Potential Role as a Tumour Biomarker

Identification of stably expressed reference small non‐coding RNAs for microRNA quantification in high‐grade serous ovarian carcinoma tissues

Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes

RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients

Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients

964P Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways

Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients

HE4 in gynecological cancers: report of a European investigators and experts meeting

Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis

Induction of tumour-specific CD8 cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer

Intracellular localization of full-length and truncated hepatitis C virus core protein expressed in mammalian cells

Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer

172 Trefoil factor 3: a potential diagnostic and prognostic marker whose expression contributes to malignant feature in endometrial carcinoma cells

Suchergebnisse filtern